11.07. Thu
Mixed-reality simulators to improve training for the examination of premature babies in Poland
University Clinical Hospital, Poland, is the first in the world to benefit from four Eyesi Indirect ROP Simulators, which will be used to train ophthalmologists in Warsaw, Kraków, Katowice, and Poznań.
08.07. Mon
Haag-Streit launches Eyesi Surgical Software 4.0
Haag-Streit is delighted to announce the launch of Eyesi Surgical Software 4.0, which is available now for the Eyesi Surgical Simulator.
15.05. Wed
Haag-Streit launches 3D imaging option for the Imaging Module 910
Haag-Streit continues to innovate within the field of slit lamp imaging with 3D-ready functionality
13.05. Mon
Introducing the instrument holder for the Eyesi Surgical
Protect your instruments – protect your investment
08.04. Mon
Haag-Streit launches “Slit Lamp Imaging Competition 2024”
Haag-Streit’s “Slit Lamp Imaging Competition 2024” includes a new video category
02.04. Tue
Haag-Streit launches Eyesi Indirect Ophthalmoscope ROP Simulator
Haag-Streit has launched the Eyesi Indirect Ophthalmoscope ROP Simulator (Eyesi Indirect ROP) for training of retinal examinations on premature babies and classification of retinopathy of prematurity (ROP).
07.02. Wed
Eyestar 900 elevates practice workflow for one of the UK’s top eye surgeons
Haag-Streit is delighted to share a successful collaboration with Dr. Ali Mearza of OCL Vision, London.
12.12. Tue
Haag-Streit launches new global website
Haag-Streit is pleased to announce the launch of its new global website
18.10. Wed
Haag-Streit strengthens global presence with the launch of Haag-Streit Japan
Haag-Streit has announced the establishment of Haag-Streit Japan K.K. This strategic move reinforces Haag-Streit’s commitment to serving the Asian market and further solidifies its regional presence following recent expansions into China and Singapore.
12.10. Thu
Haag-Streit announces winners of its ‘Slit Lamp Imaging Competition 2023’
We are delighted to release the results of our ‘Slit Lamp Imaging Competition 2023’.